{
 "page": "https://omnirx.org/conditions/chronic-kidney-disease/semaglutide",
 "edition": "2026-11",
 "editionRoot": "006ab9a329709cbe",
 "license": "https://omnirx.org/license",
 "generated": "2026-11-11",
 "condition": {
  "id": "chronic-kidney-disease",
  "name": "Chronic Kidney Disease"
 },
 "drug": {
  "ingredient": "SEMAGLUTIDE",
  "brands": [
   "Ozempic"
  ]
 },
 "orderIsRanking": false,
 "orderNote": "Fixed order: the FDA label, public Medicare facts, the manufacturer, charities, research access. It is not a ranking and no saving is computed.",
 "routes": [
  {
   "id": "label",
   "title": "Why this drug and this condition are paired",
   "found": true,
   "quote": "to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes mellitus and chronic kidney disease.",
   "context": "risk-reduction",
   "source": "https://api.fda.gov/drug/label.json?search=set_id:%2242bdd912-2393-44c4-b7e0-47672ca28991%22&limit=1",
   "readOn": "2026-11-10",
   "fact_id": "f12b376eff5d78374f1b1564"
  },
  {
   "id": "part-d",
   "title": "Medicare Part D: the yearly out-of-pocket threshold",
   "found": true,
   "text": "$2,400 in 2027 ($2,100 in 2026)",
   "source": "https://www.cms.gov/files/document/2027-announcement.pdf",
   "readOn": "2026-11-08"
  },
  {
   "id": "price",
   "title": "Medicare negotiated price",
   "found": true,
   "usd30DaySupply": 274,
   "effective": "2027-01-01",
   "source": "https://www.cms.gov/initiatives/medicare-prescription-drug-affordability/overview/medicare-drug-price-negotiation-program/selected-drugs-negotiated-prices",
   "readOn": "2026-11-06"
  },
  {
   "id": "program",
   "title": "Manufacturer and foundation programs",
   "found": true,
   "programs": [
    {
     "name": "Ozempic Savings (via NovoCare)",
     "url": "https://omnirx.org/assistance/ozempic-patient-assistance",
     "programPageIsExternal": false,
     "inCurrentList": true,
     "note": null,
     "listKind": null,
     "status": "limited",
     "statusRead": "2026-11-07",
     "fact_id": null
    },
    {
     "name": "Novo Nordisk PAP (NovoCare)",
     "url": "https://omnirx.org/assistance/novo-nordisk-pap",
     "programPageIsExternal": false,
     "inCurrentList": true,
     "note": "0.5 mg, 1 mg, or 2 mg",
     "listKind": "Available Products (PAP product list PDF)",
     "status": "limited",
     "statusRead": "2026-11-07",
     "fact_id": "b83b625fde7d857724507d5f"
    },
    {
     "name": "Diabetes Medication Assistance (Multiple Programs)",
     "url": "https://omnirx.org/assistance/diabetes-medication-assistance",
     "programPageIsExternal": false,
     "inCurrentList": true,
     "note": null,
     "listKind": null,
     "status": null,
     "statusRead": null,
     "fact_id": null
    }
   ]
  },
  {
   "id": "funds",
   "title": "Charitable funds for Chronic Kidney Disease",
   "found": true,
   "fundsHeld": 2,
   "open": 0,
   "readOn": "2026-11-08",
   "openFunds": [],
   "hubUrl": "https://omnirx.org/conditions/chronic-kidney-disease"
  },
  {
   "id": "trials",
   "title": "Clinical trial access",
   "found": true,
   "recruitingInterventionalTrials": 154,
   "source": "https://clinicaltrials.gov/search?intr=semaglutide&aggFilters=status%3Arec%2CstudyType%3Aint",
   "readOn": "2026-11-07",
   "fact_id": "baa5cb4f378eec5ac335abd6"
  }
 ]
}